ivWatch, LLC

Don't Trust the Flush! Click here to learn about the main causes of IV infiltrations and download a clinical education tool for your units. The scary truth? IV infiltrations are going to happen, even in the most skilled hands, but severe injuries are highly avoidable. Real-time IV site monitoring from ivWatch detects IV injuries before they’re visible, and before harm is done to the patient. Knowing the causes of infiltrations will help you change the way you assess IV sites. Read more: https://lnkd.in/eXneRjfR

Know the vastness of the issue and demand change in IV therapy.   Waiting to see the injury occur and then taking action is an age-old practice that is simply not effective.   Extravasations have been censored for too long and are a significant healthcare crisis due to their potential to cause severe patient harm like injuries, surgical intervention, disfigurement, and emotional distress, along with prolonged treatment, and increase healthcare costs. #healthcare #patientcare #extravasation #ivinjury

𝗪𝗔𝗥𝗡𝗜𝗡𝗚: Infusion pumps are designed to deliver fluids, but they do not detect infiltrations. ivWatch is the only FDA-cleared and CE-Marked device able to alert clinicians at the earliest signs of infiltration and extravasation events.   It’s time to step up IV monitoring for extravasations to: • Mitigate legal and reputational risks • Reduce drug errors • Improve patient safety • Enhance clinician confidence • Advance continuous quality improvement programs #PatientSafety #InfiltrationDetection #ivWatch #ContinuousMonitoring

Iron infusions have gained popularity as an effective treatment for iron deficiency, particularly when oral iron supplements are ineffective or poorly tolerated. However, there are risks associated with iron infusions. When iron leaks outside the vein, it can cause skin staining, swelling, pain, and permanent discoloration at the infusion site. These injuries can also have lasting psychological effects, including body image concerns. Early detection is the only solution with continuous monitoring technology to take immediate corrective action to prevent these adverse outcomes. Learn more here: https://lnkd.in/ewXYM2ka

We are proud to announce that ivWatch has received the European Union's Medical Device Regulation (MDR) Certificate, a significant regulatory milestone that allows us to continue our strategic global expansion in key markets including Europe, the UK and target countries in the GCC. With over nine million hours of patient monitoring and more than 300,000 patients benefiting from our continuous patient monitoring technology, this further demonstrates our commitment to patient safety and delivering best practices and quality IV therapy. Read more: https://lnkd.in/ek8v_Sys

We are proud to announce that ivWatch has received the European Union's Medical Device Regulation (MDR) Certificate, a significant regulatory milestone that allows us to continue our strategic global expansion in key markets including Europe, the UK and target countries in the GCC. With over nine million hours of patient monitoring and more than 300,000 patients benefiting from our continuous patient monitoring technology, this further demonstrates our commitment to patient safety and delivering best practices and quality IV therapy. Read more: https://lnkd.in/ek8v_Sys

Neonates face the highest risk of IV infiltration and extravasation due to the fragility of their skin and vessels combined with the urgent need for life-sustaining IV therapy.   Medications like antibiotics, vasopressors, and respiratory stimulants, while essential, can cause severe tissue damage if the infusate infiltrates. Since IV access is challenging in neonates and errors can occur rapidly, continuous monitoring is critical.   ivWatch offers a miniaturized sensor that that sits directly next to the IV site and can detect fluid infiltrating with 99% sensitivity. The smallest drop of fluid can cause severe harm. The time is now to stop IV harm with continuous IV site monitoring.   Learn more: https://lnkd.in/ez95fWWp  #nicu #ivtherapy #ivinfiltration #extravasation 

At ivWatch, we’re dedicated to supporting hospitals, clinicians, and patients by delivering high-quality products that we stand behind. We go beyond just providing IV therapy safety solutions; we offer a holistic point of view with onsite clinical support to ensure continuous quality improvement. #clinicalteam #healthcare #ivtherapy #ivwatch Tony Petrocelli RN, BSN, Jackie Wallace, Mark Fletcher, RN, BSN

All extravasations are infiltrations, but not all infiltrations are extravasations. An extravasation specifically refers to the leakage of a toxic or vesicant medication, which can cause severe tissue damage, leading to serious injuries, including tissue necrosis, blisters, compartment syndrome, and life-threatening patient harm.   Infiltration occurs when IV fluid or medication leaks into the surrounding tissue instead of being delivered into the vein. Typically, people think infiltrations aren’t as harmful because the medication being delivered isn’t as severe. Unfortunately, all infiltrations and extravasations can lead to serious complications for the patient.   No matter what fluid you have infusing, early detection and proactive protocols can prevent severe patient harm due to IV therapy. With ivWatch, clinicians have a second set of eyes at the bedside.   #infiltration #ivinjury #ivtherapy #vesicant  

The current healthcare standard for IV monitoring varies from every 5 minutes for high-risk drugs to every 4 hours for seemingly less complex infusions. Some infusions will go unchecked overnight or for extended periods of time. ivWatch monitors the IV site 𝟭𝟴,𝟬𝟬𝟬𝘅 𝗽𝗲𝗿 𝗵𝗼𝘂𝗿—𝟱𝘅 𝗽𝗲𝗿 𝘀𝗲𝗰𝗼𝗻𝗱— and outperforms the traditional methods to help address: • the strained clinician-to-patient ratios • staffing turnover • the circuit of traveling nurses • seasoned nurses leaving the field. Routine IV checks are not enough and leave clinicians and facilities liable. #Healthcare #IVMonitoring #PatientSafety